Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Basu, Partha; G. Malvi, Sylla; Joshi, Smita; Bhatla, Neerja; Muwonge, Richard; Lucas, Eric; Verma, Yogesh; Okkuru Esmy, Pulikkottil; Rani Poli, Usha; Shah, Anand; Zomawia, Eric; Pimple, Sharmila; Jayant, Kasturi; Hingmire, Sanjay; Chiwate, Aruna; Divate, Uma; Vashist, Shachi; Mishra, Gauravi; Jadhav, Radhika; Siddiqi, Maqsood; Sankaran, Subha; R. Prabhu, Priya; Pillai Rameshwari Ammal Kannan, Thiraviam; Varghese, Rintu; S. Shastri, Surendra; Anantharaman, Devasena; Gheit, Tarik; Tommasino, Massimo; Sauvaget, Catherine; Radhakrishna Pillai, M.; Sankaranarayanan, Rengaswamy

doi:10.1016/s1470-2045(21)00453-8

Public

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Published in The Lancet Oncology • Oct 9, 2021

Authors:

Partha Basu

Sylla G. Malvi

Smita Joshi

Abstract

BACKGROUND: A randomised trial designed to compare three and two doses of quadrivalent human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort study after suspension of HPV vaccination in trials by the Indian Government. In this Article, the revised aim of the cohor...

Subject

Medicine

Cohort

Vaccination

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!